April 16, 2018 in Biotech Industry News Kineta starts drug development collaboration with Genentech Kineta Inc 4 Like Post Comments Off on Kineta starts drug development collaboration with Genentech Read More
April 16, 2018 in Biotech Industry News Kineta to Collaborate on the Development of a Novel Non-Opioid Pain Therapy with Genentech Kineta Inc 4 Like Post Comments Off on Kineta to Collaborate on the Development of a Novel Non-Opioid Pain Therapy with Genentech Read More
April 16, 2018 in Biotech Industry News Seattle biotech Kineta teams up with Genentech to create chronic pain medicine Kineta Inc 4 Like Post Comments Off on Seattle biotech Kineta teams up with Genentech to create chronic pain medicine Read More
April 16, 2018 in Biotech Industry News Kineta signs multi-million dollar collaboration with Genentech to develop non-opioid pain medication Kineta Inc 4 Like Post Comments Off on Kineta signs multi-million dollar collaboration with Genentech to develop non-opioid pain medication Read More
April 16, 2018 in Biotech Industry News Kineta inks $360 million-plus deal with Genentech for chronic pain drug Kineta Inc 3 Like Post Comments Off on Kineta inks $360 million-plus deal with Genentech for chronic pain drug Read More
April 16, 2018 in Biotech Industry News Roche partners with Kineta to develop non-opioid pain therapy Kineta Inc 3 Like Post Comments Off on Roche partners with Kineta to develop non-opioid pain therapy Read More
April 16, 2018 in Biotech Industry News Genentech, Kineta to Partner on Non-Opioid Pain Treatments Kineta Inc 3 Like Post Comments Off on Genentech, Kineta to Partner on Non-Opioid Pain Treatments Read More
April 16, 2018 in Biotech Industry News NAChR average pain drug, Kineta bid bags Genentech deal for as much as $359M+ Kineta Inc 3 Like Post Comments Off on NAChR average pain drug, Kineta bid bags Genentech deal for as much as $359M+ Read More
April 16, 2018 in Biotech Industry News Kineta, Roche’s Genentech strike chronic pain deal Kineta Inc 3 Like Post Comments Off on Kineta, Roche’s Genentech strike chronic pain deal Read More
April 16, 2018 in Biotech Industry News Kineta inks $360 million-plus deal with Genentech for chronic pain drug Kineta Inc 3 Like Post Comments Off on Kineta inks $360 million-plus deal with Genentech for chronic pain drug Read More
